Northwestern Medicine scientists have shown that a molecule called tenascin-C drives the excess scar buildup seen in fibrotic diseases.
Browsing: Nora Dunne
Herbert Meltzer, MD, professor of Psychiatry and Behavioral Sciences, Pharmacology and Physiology, has been chosen to receive a Pioneer in Psychopharmacology Award from the International College of Neuropsychopharmacology.
Patients with psoriasis saw their disease completely or almost completely cleared with a new drug called ixekizumab in three recent clinical trials led by a Northwestern Medicine investigator
Northwestern Medicine scientists explore research that has shown how the balanced activities of two protein families regulate gene expression during embryonic development and how mutations that tip this balance lead to cancer.
Mutations in a gene called TMEM230 were definitively linked to confirmed cases of the common movement disorder in a recent Northwestern Medicine study.
Medical student Derek Hsu studies the incidence and outcomes of rare skin disorders in order to develop predictors of mortality, information that could help clinicians prevent and treat the conditions.
A new drug safely and effectively treats patients with ulcerative colitis, according to a recent study co-authored by Northwestern Medicine investigator Stephen Hanauer, MD.
Navdeep Chandel, PhD, David W. Cugell Professor of Medicine, has received the National Cancer Institute’s Outstanding Investigator Award to explore how mitochondrial metabolism plays a role in cancer.
A minimally invasive procedure to repair aortic stenosis may be preferable to open-heart surgery when treating patients at intermediate risk of surgical mortality, according to recent research.
Some high-risk medical devices used in obstetrics and gynecology were approved by the FDA based on flawed data, according to a recent study conducted by Northwestern Medicine residents.